Recombinant Human EDNRA Protein，His

EDNRA, or endothelin receptor type A, is a G protein-coupled receptor that plays a crucial role in various physiological processes, including vascular tone regulation and cell proliferation. Dysregulation of EDNRA signaling has been implicated in several cardiovascular diseases, such as hypertension, heart failure, and pulmonary arterial hypertension. Given its significance in these pathologies, there has been growing interest in the recombinant production of EDNRA to study its structure, function, and potential as a therapeutic target. The development of recombinant EDNRA proteins allows for detailed biochemical assays and crystal structure analysis, which are essential for understanding receptor activation mechanisms and ligand interactions. These studies can also facilitate the identification of novel small molecule inhibitors or modulators, potentially leading to innovative treatments for EDNRA-related diseases. Furthermore, the use of recombinant proteins in cellular assays helps elucidate the downstream signaling pathways activated by EDNRA, enhancing our understanding of how alterations in this receptor contribute to disease states. Collectively, research on recombinant EDNRA not only advances our fundamental knowledge of endothelin receptor biology but also holds promise for clinical applications aimed at addressing various cardiovascular conditions.